Salutas Pharma GmbH - etsinnän tulokset

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

etoricoxib 30 mg film-coated tablets

rowex ltd - etoricoxib - film-coated tablet - 30 milligram(s) - coxibs; etoricoxib - anti-inflammatory and antirheumatic products, non-steroids, coxibs - for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. for the short-term treatment of moderate pain associated with dental surgery

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

etoricoxib 90 mg film-coated tablets

rowex ltd - etoricoxib - film-coated tablet - 90 milligram(s) - coxibs; etoricoxib - anti-inflammatory and antirheumatic products, non-steroids, coxibs - for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. for the short-term treatment of moderate pain associated with dental surgery

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

etoricoxib 120 mg film-coated tablets

rowex ltd - etoricoxib - film-coated tablet - 120 milligram(s) - coxibs; etoricoxib - anti-inflammatory and antirheumatic products, non-steroids, coxibs - for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. for the short-term treatment of moderate pain associated with dental surgery

Euroopan unioni - englanti - EMA (European Medicines Agency)

ibandronic acid sandoz

sandoz gmbh - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases, bisphosphonates - ibandronic acid sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.,